Beta Bionics, Inc. — Director's Dealing 2025

Mar 3, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Beta Bionics, Inc. (BBNX)
CIK: 0001674632
Period of Report: 2025-02-27

Reporting Person: Hopman Mark (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-27	Common Stock	A	35000	—	Acquired	35000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-27	Employee Stock Option (right to buy)	$19.91	A	52000	Acquired	2035-02-26	Common Stock (52000)	Direct

Footnotes

F1: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.

F2: The shares subject to this option shall vest in 36 equal monthly installments measured from February 27, 2025.